GW Pharmaceuticals PLC Holding(s) in Company (4823E)

TIDMGWP

RNS Number : 4823E

GW Pharmaceuticals PLC

10 May 2013

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 
-------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or the underlying              GW Pharmaceuticals PLC 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
--------------------------------------------------  ---------------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
-------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
-----------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
-----------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
-----------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights                                 x 
-----------------------------------------------------------------------------  ------- 
 Other (please        Change of custodian 
  specify): 
-------------------  --------------------------------------------------------  ------- 
 3. Full name of person(s) subject                Farallon Capital Management L.L.C 
  to the 
  notification obligation: (iii) 
--------------------------------------------  ---------------------------------------- 
 4. Full name of shareholder(s)                                  N/A 
  (if different from 3.):(iv) 
--------------------------------------------  ---------------------------------------- 
 5. Date of the transaction and date                         9 May 2013 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
--------------------------------------------  ---------------------------------------- 
 6. Date on which issuer notified:                           9 May 2013 
--------------------------------------------  ---------------------------------------- 
 7. Threshold(s) that is/are crossed 
  or 
  reached: (vi, vii)                                             5% 
--------------------------------------------  ---------------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------------------------ 
 Class/type   Situation previous                        Resulting situation after the triggering 
 of            to the triggering                         transaction 
 shares        transaction 
 
 if 
 possible 
 using 
 the ISIN 
 CODE 
-----------  ----------------------------------------  ----------------------------------------------------------------- 
              Number            Number                  Number     Number of voting         % of voting rights 
               of                of                     of          rights                   (x) 
               Shares            Voting                 shares 
                                 Rights 
-----------  ----------------  ----------------------  ---------  -----------------------  ----------------------------- 
                                                        Direct     Direct        Indirect   Direct         Indirect 
                                                                    (xi)          (xii) 
-----------  ---  ----  -----     ------  -----  ----  ---------  ------------  ---------  -------------  -------------- 
 
 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of financial       Expiration        Exercise/                     Number of voting            % of voting 
  instrument              date (xiii)       Conversion Period             rights that may             rights 
                                            (xiv)                         be 
                                                                          acquired if the 
                                                                          instrument is 
                                                                          exercised/ converted. 
----------------------  ----------------  ----------------------------  --------------------------  -------------------- 
  American depository                                                            Below 5%                 Below 5% 
      US36197T1034 
----------------------  ----------------  ----------------------------  --------------------------  -------------------- 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of           Exercise        Expiration     Exercise/        Number of voting             % of voting rights 
 financial          price           date (xvii)    Conversion       rights instrument            (xix, xx) 
 instrument                                        period           refers to 
                                                   (xviii) 
----------------  --------------  -------------  ---------------  ---------------------------  ------------------------- 
                                                                                                Nominal       Delta 
----------------  --------------  -------------  ---------------  ---------------------------  ------------  ----------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                                         Percentage of voting rights 
--------------------------------------------------------------  -------------------------------------------------------- 
 Below 5%                                                        Below 5% 
--------------------------------------------------------------  -------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
---------------------------------------------------------------------------------------- 
 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-----------------------------------------------------  --------------------------------- 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
-----------------------------------------------------  --------------------------------- 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
-----------------------------------------------------  --------------------------------- 
 
                                           The underlying shares to which the 
  13. Additional information:               ADRs described in section 8. B above 
                                            relate have now been admitted to trading 
                                            on the Alternative Investment Market 
                                            and the issuer has made a total voting 
                                            rights announcement reflecting the 
                                            newly issued shares. Therefore, while 
                                            the ADS position has not changed, 
                                            the percentage of the issuer's total 
                                            voting rights represented by that 
                                            position has, as a result of the admission 
                                            of the new shares to trading, dropped 
                                            below 5%. 
----------------------------------------  ---------------------------------------------- 
 14. Contact name:                         Elizabeth Wallace 
----------------------------------------  ---------------------------------------------- 
 15. Contact telephone number:             + 1 415 421 2132 
----------------------------------------  ---------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEASSEFASDEFF